Literature DB >> 12556667

Epidemiology of hypertension and cardiovascular disease in African Americans.

John M Flack1, Kieth C Ferdinand, Samar A Nasser.   

Abstract

Hypertension is a major cause of cardiovascular-renal morbidity and mortality and all-cause mortality. It is a highly significant problem for African Americans; about 30% of all deaths in this population are attributable to hypertension. Compared with whites, hypertension in African Americans is more prevalent, occurs earlier in life, is more severe, and is more often associated with target organ injury such as left ventricular hypertrophy and other cardiovascular complications. Only 25% of all African Americans with hypertension and fewer than 50% of those receiving drug treatment attain a blood pressure <140/90 mm Hg. These control rates are somewhat less than in white Americans. Enhanced awareness and understanding of the epidemiologic patterns of hypertension, other cardiovascular risk factors, risk-factor control rates, and factors influencing these control rates should lead to better approaches to risk-factor control. This most likely would result in a reduction of cardiovascular disease complications. Copyright 2003 Le Jacq Communications, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12556667      PMCID: PMC8101861          DOI: 10.1111/j.1524-6175.2003.02152.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  38 in total

1.  Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies.

Authors:  J Thomas; D J Thomas; T Pearson; M Klag; L Mead
Journal:  J Health Care Poor Underserved       Date:  1997-08

Review 2.  Pathophysiology and treatment implications of hypertension in the African-American population.

Authors:  M Rahman; J G Douglas; J T Wright
Journal:  Endocrinol Metab Clin North Am       Date:  1997-03       Impact factor: 4.741

3.  Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the CARDIA study.

Authors:  J M Flack; J M Gardin; C Yunis; K Liu
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

Review 4.  Coronary heart disease in African Americans: primary and secondary prevention.

Authors:  L T Clark; O Emerole
Journal:  Cleve Clin J Med       Date:  1995 Sep-Oct       Impact factor: 2.321

Review 5.  Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage.

Authors:  J M Flack; G A Mensah; C M Ferrario
Journal:  Curr Med Res Opin       Date:  2000       Impact factor: 2.580

6.  Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA Study). The Coronary Artery Risk Development in Young Adults Study.

Authors:  S S Gidding; K Liu; D E Bild; J Flack; J Gardin; K J Ruth; A Oberman
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

7.  African American Study of Kidney Disease and hypertension (AASK)--clinical trial update.

Authors:  L Agodoa
Journal:  Ethn Dis       Date:  1998       Impact factor: 1.847

8.  Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  J Community Health       Date:  1984

Review 9.  Improving compliance and increasing control of hypertension: needs of special hypertensive populations.

Authors:  L T Clark
Journal:  Am Heart J       Date:  1991-02       Impact factor: 4.749

10.  Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1982-09-24       Impact factor: 56.272

View more
  47 in total

1.  Trust, medication adherence, and hypertension control in Southern African American men.

Authors:  Keith Elder; Zo Ramamonjiarivelo; Jacqueline Wiltshire; Crystal Piper; Wendy S Horn; Keon L Gilbert; Sandral Hullett; Jeroan Allison
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension.

Authors:  Yendelela L Cuffee; J Lee Hargraves; Milagros Rosal; Becky A Briesacher; Antoinette Schoenthaler; Sharina Person; Sandral Hullett; Jeroan Allison
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

Review 3.  Managing cardiovascular risk in minority patients.

Authors:  Keith C Ferdinand
Journal:  J Natl Med Assoc       Date:  2005-04       Impact factor: 1.798

Review 4.  Public Health, Hypertension, and the Emergency Department.

Authors:  Aaron Brody; Alex Janke; Vineet Sharma; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 5.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 6.  Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines.

Authors:  Stephen K Williams; Joseph Ravenell; Sara Seyedali; Sam Nayef; Gbenga Ogedegbe
Journal:  Prog Cardiovasc Dis       Date:  2016-09-29       Impact factor: 8.194

Review 7.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

9.  African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.

Authors:  M Khaleghi; U Saleem; R D McBane; T H Mosley; I J Kullo
Journal:  J Thromb Haemost       Date:  2008-10-30       Impact factor: 5.824

10.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

Authors:  Mahyar Khaleghi; Umer Saleem; Nils G Morgenthaler; Stephen T Turner; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-02-12       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.